Article Details

HC Wainwright Reaffirms Their Buy Rating on GT Biopharma (GTBP)

Retrieved on: 2021-06-28 10:30:00

Tags for this article:

Click the tags to see associated articles and topics

HC Wainwright Reaffirms Their Buy Rating on GT Biopharma (GTBP). View article details on hiswai:

Excerpt

GT Biopharma has an analyst consensus of Moderate Buy, with a price target consensus of $25.50, a 77.8% upside from current levels. In a report ...

Article found on: www.analystratings.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo